Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project
Bisphosphonates are the most commonly prescribed medications for the treatment of osteoporosis. Despite evidence supporting the anti-fracture efficacy of aminobisphosphonates approximately 50% of patients do not follow their prescribed treatment regimen and/or discontinue treatment within the first...
Saved in:
Main Authors: | F. Bertoldo (Author), L. Dalle Carbonare (Author), V. Lo Cascio (Author) |
---|---|
Format: | Book |
Published: |
PAGEPress Publications,
2011-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of zoledronic acid in the treatment of glucocorticoid-induced osteoporosis
by: Ege Can Serefoglu, et al.
Published: (2010) -
Zoledronic acid infusion for prevention and treatment of osteoporosis
by: John A Sunyecz
Published: (2010) -
How zoledronic acid improves osteoporosis by acting on osteoclasts
by: Biao Wang, et al.
Published: (2022) -
Retrospective Study of the Effects of Zoledronic Acid on Muscle Mass in Osteoporosis Patients
by: Huang CF, et al.
Published: (2021) -
Treatment of osteoporosis with annual iv zoledronic acid: effects on hip fracture
by: Rol, et al.
Published: (2009)